Wednesday, November 18, 2020
Food, Pharmaceutical & Bioengineering Division (15) (PreRecorded+)
The blood-brain barrier presents a major obstacle to brain drug delivery. We have developed several different enabling platforms for the identification of antibodies against blood-brain barrier resident receptors that can be used to ferry drug cargo into the brain. Here we will describe our recent efforts to identify and deploy these antibodies.
See more of this Session: Innovative Methods in Bioengineering
See more of this Group/Topical: Food, Pharmaceutical & Bioengineering Division
See more of this Group/Topical: Food, Pharmaceutical & Bioengineering Division